MA52591A - Échafaudage peptidique autoassemblé - Google Patents

Échafaudage peptidique autoassemblé

Info

Publication number
MA52591A
MA52591A MA052591A MA52591A MA52591A MA 52591 A MA52591 A MA 52591A MA 052591 A MA052591 A MA 052591A MA 52591 A MA52591 A MA 52591A MA 52591 A MA52591 A MA 52591A
Authority
MA
Morocco
Prior art keywords
peptidic
scaffolding
assembled
self
peptidic scaffolding
Prior art date
Application number
MA052591A
Other languages
English (en)
Inventor
Keith Douglas Miller
Original Assignee
Hexamer Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hexamer Therapeutics Inc filed Critical Hexamer Therapeutics Inc
Publication of MA52591A publication Critical patent/MA52591A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/64—Medicinal preparations containing antigens or antibodies characterised by the architecture of the carrier-antigen complex, e.g. repetition of carrier-antigen units
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/735—Fusion polypeptide containing domain for protein-protein interaction containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA052591A 2018-07-12 2019-07-12 Échafaudage peptidique autoassemblé MA52591A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201862697132P 2018-07-12 2018-07-12

Publications (1)

Publication Number Publication Date
MA52591A true MA52591A (fr) 2021-06-02

Family

ID=69142622

Family Applications (1)

Application Number Title Priority Date Filing Date
MA052591A MA52591A (fr) 2018-07-12 2019-07-12 Échafaudage peptidique autoassemblé

Country Status (12)

Country Link
US (1) US20210268105A1 (fr)
EP (2) EP3826661A4 (fr)
JP (2) JP2021531337A (fr)
KR (1) KR20210065086A (fr)
CN (1) CN112512552A (fr)
AU (2) AU2019300038C1 (fr)
BR (1) BR112021000455A2 (fr)
CA (1) CA3105706A1 (fr)
MA (1) MA52591A (fr)
MX (1) MX2021000444A (fr)
WO (1) WO2020014609A2 (fr)
ZA (1) ZA202100952B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4183417A1 (fr) * 2019-09-12 2023-05-24 Hexamer Therapeutics, Inc. Immunotherapie pour le traitement du cancer de la prostate
WO2021226026A2 (fr) * 2020-05-04 2021-11-11 Hexamer Therapeutics, Inc. Vaccins contre des agents pathogènes viraux

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60031792T2 (de) * 1999-12-08 2007-02-22 Intellect Neurosciences, Inc. Schimärische amyloid-beta peptide
JP5576610B2 (ja) * 2006-02-20 2014-08-20 フィロジカ リミテッド ペプチド構造のライブラリーの構築およびスクリーニング方法
US9217011B2 (en) * 2007-09-07 2015-12-22 Complix Nv Non-natural proteinaceous scaffold made of three non-covalently associated peptides
BRPI0911501A2 (pt) * 2008-04-29 2015-07-28 Monsanto Technology Llc Genes e usos para melhoramento de plantas.
WO2013009971A1 (fr) * 2011-07-12 2013-01-17 E. I. Du Pont De Nemours And Company Procédé de détection et de criblage et matériaux utiles dans l'exécution de celui-ci
EP2771349B1 (fr) * 2011-09-16 2020-02-26 Iogenetics, LLC. Procédés bio-informatiques de détermination de liaisons peptidiques
US20150374844A1 (en) * 2013-02-15 2015-12-31 University Of Pennsylvania Novel ph -switchable peptides for membrane insertion and pore formation
CA2959201C (fr) * 2013-09-16 2021-06-01 The University Of Queensland Micro-capsules et nano-capsules de silice et procedes de fabrication de celles-ci
WO2015164798A1 (fr) * 2014-04-25 2015-10-29 Tria Bioscience Corp. Compositions de support d'haptène synthétique et procédés
US11725041B2 (en) * 2016-08-11 2023-08-15 The Council Of The Queensland Institute Of Medical Research Immune-modulating compounds

Also Published As

Publication number Publication date
AU2019300038A1 (en) 2021-02-04
KR20210065086A (ko) 2021-06-03
CN112512552A (zh) 2021-03-16
AU2019300038B2 (en) 2023-01-12
CA3105706A1 (fr) 2020-01-16
ZA202100952B (en) 2023-10-25
EP3826661A2 (fr) 2021-06-02
JP2021531337A (ja) 2021-11-18
EP4218928A3 (fr) 2023-12-13
AU2019300038C1 (en) 2024-01-04
BR112021000455A2 (pt) 2021-04-06
WO2020014609A4 (fr) 2020-04-16
JP2024036461A (ja) 2024-03-15
WO2020014609A2 (fr) 2020-01-16
WO2020014609A3 (fr) 2020-02-20
EP3826661A4 (fr) 2022-08-31
AU2023202175A1 (en) 2023-05-04
MX2021000444A (es) 2021-05-27
EP4218928A2 (fr) 2023-08-02
US20210268105A1 (en) 2021-09-02

Similar Documents

Publication Publication Date Title
MA52591A (fr) Échafaudage peptidique autoassemblé
ES1178283Y (es) Lienzo auto-montable
MA52588A (fr) Macrocyclase peptidique
DK3752258T3 (da) Trampolin
MA54534A (fr) Antagonistes
DK3587968T3 (da) Fluidsystem
MA49925A (fr) Claie
DE112019000442A5 (de) Ringtilgereinrichtung
NO20181678A1 (no) Rissanviser
JP1628555S (ja) たい焼
JP1628556S (ja) たい焼
UA38118S (uk) Малярний пензель-макловиця
UA38022S (uk) Малярний пензель-макловиця
ES1218724Y (es) Terrario
ES1224156Y (es) Ecobolsera
UA38581S (uk) Термокухоль
UA38632S (uk) Електролобзик
UA38602S (uk) Термокухоль
UA38411S (uk) Термокухоль
UA38612S (uk) Електролобзик
UA38627S (uk) Пневмофарбопульт
UA38598S (uk) Пневмофарбопульт
UA38585S (uk) Електролобзик
UA38606S (uk) Електролобзик
UA38633S (uk) Електролобзик